Your browser doesn't support javascript.
loading
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.
Blohmke, Christoph J; Darton, Thomas C; Jones, Claire; Suarez, Nicolas M; Waddington, Claire S; Angus, Brian; Zhou, Liqing; Hill, Jennifer; Clare, Simon; Kane, Leanne; Mukhopadhyay, Subhankar; Schreiber, Fernanda; Duque-Correa, Maria A; Wright, James C; Roumeliotis, Theodoros I; Yu, Lu; Choudhary, Jyoti S; Mejias, Asuncion; Ramilo, Octavio; Shanyinde, Milensu; Sztein, Marcelo B; Kingsley, Robert A; Lockhart, Stephen; Levine, Myron M; Lynn, David J; Dougan, Gordon; Pollard, Andrew J.
Afiliación
  • Blohmke CJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK christoph.blohmke@paediatrics.ox.ac.uk.
  • Darton TC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK.
  • Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK.
  • Suarez NM; Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH 43210.
  • Waddington CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK.
  • Angus B; Nuffield Department of Medicine, University of Oxford, OX1 2JD, England, UK.
  • Zhou L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK.
  • Hill J; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Clare S; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Kane L; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Mukhopadhyay S; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Schreiber F; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Duque-Correa MA; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Wright JC; Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Roumeliotis TI; Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Yu L; Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Choudhary JS; Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Mejias A; Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH 43210.
  • Ramilo O; Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH 43210.
  • Shanyinde M; Nuffield Department of Primary Care Health Sciences, University of Oxford, OX1 2JD, England, UK.
  • Sztein MB; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201.
  • Kingsley RA; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Lockhart S; Emergent Product Development UK, Emergent BioSolutions, Wokingham RG41 5TU, England, UK.
  • Levine MM; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201.
  • Lynn DJ; EMBL Australia Group, South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA 5000, Australia School of Medicine, Flinders University, Bedford Park, SA 5042, Australia.
  • Dougan G; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK.
J Exp Med ; 213(6): 1061-77, 2016 05 30.
Article en En | MEDLINE | ID: mdl-27217537
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Salmonella typhi / Triptófano / Fiebre Tifoidea / Interferón Tipo I / Interferón gamma / Inmunomodulación Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Exp Med Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Salmonella typhi / Triptófano / Fiebre Tifoidea / Interferón Tipo I / Interferón gamma / Inmunomodulación Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Exp Med Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido